These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 8619946)
1. Influence of fraction size on the development of late radiation enteropathy. An experimental study in the rat. Langberg CW; Hauer-Jensen M Acta Oncol; 1996; 35(1):89-94. PubMed ID: 8619946 [TBL] [Abstract][Full Text] [Related]
2. Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy. Langberg CW; Sauer T; Reitan JB; Hauer-Jensen M Acta Oncol; 1996; 35(1):81-7. PubMed ID: 8619945 [TBL] [Abstract][Full Text] [Related]
3. Timing of concomitant boost irradiation affects incidence and severity of intestinal complications. Allgood JW; Langberg CW; Sung CC; Hauer-Jensen M Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):381-7. PubMed ID: 8567339 [TBL] [Abstract][Full Text] [Related]
4. Significance of overall treatment time for the development of radiation-induced intestinal complications. An experimental study in the rat. Langberg CW; Waldron JA; Baker ML; Hauer-Jensen M Cancer; 1994 May; 73(10):2663-8. PubMed ID: 8174067 [TBL] [Abstract][Full Text] [Related]
5. Influence of fractionation schedule on development of intestinal complications following localized irradiation. An experimental study in the rat. Langberg CW; Sauer T; Reitan JB; Hauer-Jensen M Acta Oncol; 1994; 33(4):403-8. PubMed ID: 8018373 [TBL] [Abstract][Full Text] [Related]
6. Intestinal complications following accelerated fractionated x-irradiation. An experimental study in the rat. Hauer-Jensen M; Poulakos L; Osborne JW Acta Oncol; 1990; 29(2):229-34. PubMed ID: 2334576 [TBL] [Abstract][Full Text] [Related]
7. Association of transforming growth factor beta (TGF-beta) immunoreactivity with specific histopathologic lesions in subacute and chronic experimental radiation enteropathy. Richter KK; Langberg CW; Sung CC; Hauer-Jensen M Radiother Oncol; 1996 Jun; 39(3):243-51. PubMed ID: 8783401 [TBL] [Abstract][Full Text] [Related]
8. Tolerance of rat small intestine to localized single dose and fractionated irradiation. Langberg CW; Sauer T; Reitan JB; Hauer-Jensen M Acta Oncol; 1992; 31(7):781-7. PubMed ID: 1476759 [TBL] [Abstract][Full Text] [Related]
9. Effects of accelerated fractionation on radiation injury of the small intestine: a new rat model. Hauer-Jensen M; Poulakos L; Osborne JW Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1205-12. PubMed ID: 3290169 [TBL] [Abstract][Full Text] [Related]
10. Increased transforming growth factor beta (TGF-beta) immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy. Richter KK; Langberg CW; Sung CC; Hauer-Jensen M Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):187-95. PubMed ID: 9300754 [TBL] [Abstract][Full Text] [Related]
11. Association of granulocyte transmigration with structural and cellular parameters of injury in experimental radiation enteropathy. Richter KK; Fagerhol MK; Carr JC; Winkler JM; Sung CC; Hauer-Jensen M Radiat Oncol Investig; 1997; 5(6):275-82. PubMed ID: 9436244 [TBL] [Abstract][Full Text] [Related]
12. Optimal interfraction interval to minimize small bowel radiation injury in treatment regimens with two fractions per day: an experimental study in a rat model. Langberg CW; Hauer-Jensen M Radiother Oncol; 1996 Dec; 41(3):249-55. PubMed ID: 9027941 [TBL] [Abstract][Full Text] [Related]
13. Models for estimating the risk of ulcers in the small intestine after localized single or fractionated irradiation. Scott BR; Langberg CW; Hauer-Jensen M Br J Radiol; 1995 Jan; 68(805):49-57. PubMed ID: 7881883 [TBL] [Abstract][Full Text] [Related]
14. Effect of ticlopidine in the prevention of radiation enteropathy. Akyurek S; Atahan L; Cengiz M; Sokmensuer C; Haberal I; Yildiz F; Onal C Br J Radiol; 2006 May; 79(941):409-14. PubMed ID: 16632621 [TBL] [Abstract][Full Text] [Related]
15. Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Langberg CW; Hauer-Jensen M; Sung CC; Kane CJ Radiother Oncol; 1994 Jul; 32(1):29-36. PubMed ID: 7938676 [TBL] [Abstract][Full Text] [Related]
16. Orazipone, a locally acting immunomodulator, ameliorates intestinal radiation injury: a preclinical study in a novel rat model. Boerma M; Wang J; Richter KK; Hauer-Jensen M Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):552-9. PubMed ID: 16965997 [TBL] [Abstract][Full Text] [Related]
17. Influence of pancreatic secretion on late radiation enteropathy in the rat. Hauer Jensen M; Sauer T; Berstad T; Nygaard K Acta Radiol Oncol; 1985; 24(6):555-60. PubMed ID: 3006446 [TBL] [Abstract][Full Text] [Related]
18. Activation of protease activated receptor 2 by exogenous agonist exacerbates early radiation injury in rat intestine. Wang J; Boerma M; Kulkarni A; Hollenberg MD; Hauer-Jensen M Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1206-12. PubMed ID: 20610041 [TBL] [Abstract][Full Text] [Related]
19. Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection. Haydont V; Gilliot O; Rivera S; Bourgier C; François A; Aigueperse J; Bourhis J; Vozenin-Brotons MC Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1471-82. PubMed ID: 17674977 [TBL] [Abstract][Full Text] [Related]